<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>22</Volume>
				<Issue>10</Issue>
				<PubDate PubStatus="epublish">
					<Year>2021</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Assessment of the Risk of Breast Cancer Development Applying NCI Tool among Iraqi Women</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>3121</FirstPage>
			<LastPage>3126</LastPage>
			<ELocationID EIdType="pii">89790</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2021.22.10.3121</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Zainab Abbas </FirstName>
					<LastName>Al Talebi</LastName>
<Affiliation>College of Science, University of Babylon, Iraq.</Affiliation>

</Author>
<Author>
					<FirstName>Seenaa Kadhum </FirstName>
					<LastName>Ali</LastName>
<Affiliation>Deptment of Chemistry, Faculty of Education for Girls, University of Kufa, Iraq.</Affiliation>

</Author>
<Author>
					<FirstName>Zinah Kadhim </FirstName>
					<LastName>Kareem</LastName>
<Affiliation>Manager of AL Mustensrya Family Center, Iraq.</Affiliation>

</Author>
<Author>
					<FirstName>Dhafer A.F</FirstName>
					<LastName>Al-Koofee</LastName>
<Affiliation>Deptment of Clinical Laboratory Science, Faculty of Pharmacy, University of Kufa, Iraq.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2020</Year>
					<Month>11</Month>
					<Day>09</Day>
				</PubDate>
			</History>
		<Abstract>Objective: As part of the bioinformatics studies, we utilized National Cancer Institute (NCI)’s Breast Cancer Risk Assessment Tool to estimate the five-year period and lifetime risk of breast cancer development among Iraqi risky women. Methods: Totally, 110 risky women aged 21-67 (mean=36±7.4) years were interviewed by a series of questions regarding the risk of breast cancer development. Moreover, 100 cases with mutation in the BRCA1 or BRCA2 genes were included. Results: Our results demonstrated that the patient’s estimated risk of breast cancer development during the next five years and lifetime (until the age 90 years) included 0.96% (p=0.211) and 9.97% (p=0.002), respectively being relatively low. Accordingly, the lifetime risk for the breast cancer development was significantly higher (10.38%) than that of 5-year. However, the age of patients was not significantly associated to the breast cancer development as there was no significant difference among various age groups. Conclusion: It was concluded that long-term or lifetime period plays as a significant risk factor for developing breast cancer among female patients who had had a screening episode in Iraq.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">breast cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Bioinformatics</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Risk Assessment Tool</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_89790_58ea1cc555d26184a9ca63299fe8682d.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
